CANC.US Tema Oncology ETF

- USD
No recent price
Total assets
217M
Expense ratio
0.78%
Dividend yield
0.05%
1-year return
+33.50%
Holdings
56
Since
2023

Fund data as reported by the issuer, updated Nov 13, 2026. Total assets are in the fund's base currency.

What does CANC.US invest in?

  • Mostly US stocks (85.5%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (83.9%)
  • Top 3 holdings: 16.8% of the fund

Asset allocation

  • US stocks 85.5%
  • Non-US stocks 18.3%
  • Cash 0.6%

Top holdings

  • Genmab AS 5.83%
  • Revolution Medicines Inc 5.71%
  • Eli Lilly and Company 5.24%
  • Merck & Company Inc 4.73%
  • Cogent Biosciences Inc 4.53%
All holdings, sectors and regions

Tema Oncology ETF performance

Sharpe ratio 1.14
This year
+23.25%
1 year
+33.50%
3 years
+27.19%
5 years
-

Volatility 19.7% over 1 year and 19.2% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

CANC.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About Tema Oncology ETF

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

Full fund profile